Effect of recombinant human soluble thrombomodulin on clinical outcomes of patients with coagulopathy after hematopoietic stem cell transplantation. [electronic resource]
Producer: 20141020Description: 442-7 p. digitalISSN:- 1600-0609
- Adult
- Aged
- Anticoagulants -- therapeutic use
- Antithrombin III -- therapeutic use
- Disseminated Intravascular Coagulation -- drug therapy
- Female
- Hematologic Neoplasms -- mortality
- Hematopoietic Stem Cell Transplantation -- adverse effects
- Heparin -- therapeutic use
- Humans
- Male
- Middle Aged
- Recombinant Proteins -- therapeutic use
- Solubility
- Survival Analysis
- Thrombomodulin -- therapeutic use
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.